US FDA Orphan Exclusivity Would Revert To Pre-Catalyst Status Under Senate Legislation

 
• By Derrick Gingery
Drugs and judge's gavel
A court ruling denies FDA from awarding orphan exclusivity for population subsets, such as adults or children. • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet